Amedisys Inc (AMED)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	751,751	928,498	922,999	1,047,967	1,171,686	986,398	977,550	963,716	962,774	960,026	967,456	981,252	980,756	982,576	985,787	920,143	886,150	847,256	806,777	819,178
Revenue (ttm)	US$ in thousands	2,348,324	2,321,060	2,289,626	2,251,407	2,236,382	2,227,658	2,229,409	2,234,331	2,223,199	2,220,452	2,215,949	2,222,225	2,214,112	2,205,500	2,196,085	2,116,978	2,071,519	2,021,492	1,972,053	1,979,978
Gross profit margin		32.01%	40.00%	40.31%	46.55%	52.39%	44.28%	43.85%	43.13%	43.31%	43.24%	43.66%	44.16%	44.30%	44.55%	44.89%	43.46%	42.78%	41.91%	40.91%	41.37%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $751,751K ÷ $2,348,324K
= 32.01%

Amedisys Inc's gross profit margin has shown fluctuations over the quarters analyzed. Starting at 41.37% in March 2020, the margin decreased slightly to 40.91% in June 2020 before bouncing back to 41.91% in September 2020. From there, the margin showed a consistent upward trend, reaching its peak at 52.39% in December 2023. However, in the following quarters, the gross profit margin experienced a decline, dropping to 32.01% by December 2024.

Overall, Amedisys Inc's gross profit margin demonstrated variability over the analyzed period, reflecting changes in the company's cost of goods sold and revenue generation. It is important to further investigate the factors driving these fluctuations to assess the company's operational efficiency and profitability.